GlucoTrack Inc. Common Stock GCTK · Stock Open GlucoTrack Inc. Common Stock in new tab
GlucoTrack Inc. Common Stock Analysis (GCTK)
Is GlucoTrack Inc. Common Stock a good investment? GlucoTrack Inc. Common Stock (GCTK) is currently trading at 1.41 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.11. This relatively low multiple may signal that GlucoTrack Inc. Common Stock is undervalued compared to historical market norms.
Investor FAQ
Does GlucoTrack Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is GlucoTrack Inc. Common Stock?
GlucoTrack Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 13, 2021 | 1:13 |
| May 20, 2024 | 1:5 |
| Feb. 4, 2025 | 1:20 |
| June 16, 2025 | 1:60 |
| Aug. 31, 2026 | Needs review |
Community Discussion